rs75329154

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_004840.3(ARHGEF6):​c.685G>A​(p.Val229Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00104 in 1,205,459 control chromosomes in the GnomAD database, including 2 homozygotes. There are 365 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0015 ( 2 hom., 45 hem., cov: 23)
Exomes 𝑓: 0.00099 ( 0 hom. 320 hem. )

Consequence

ARHGEF6
NM_004840.3 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 0.145

Publications

2 publications found
Variant links:
Genes affected
ARHGEF6 (HGNC:685): (Rac/Cdc42 guanine nucleotide exchange factor 6) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein belongs to a family of cytoplasmic proteins that activate the Ras-like family of Rho proteins by exchanging bound GDP for GTP. It may form a complex with G proteins and stimulate Rho-dependent signals. This protein is activated by PI3-kinase. Mutations in this gene can cause X-chromosomal non-specific cognitive disability. [provided by RefSeq, Jul 2008]
ARHGEF6 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Orphanet, ClinGen, Illumina
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • congenital anomaly of kidney and urinary tract
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
  • intellectual disability, X-linked 46
    Inheritance: XL Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • X-linked intellectual disability
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0073628128).
BP6
Variant X-136732149-C-T is Benign according to our data. Variant chrX-136732149-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210253.
BS2
High AC in GnomAd4 at 164 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARHGEF6NM_004840.3 linkc.685G>A p.Val229Ile missense_variant Exon 6 of 22 ENST00000250617.7 NP_004831.1 Q15052-1Q8N4Q3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARHGEF6ENST00000250617.7 linkc.685G>A p.Val229Ile missense_variant Exon 6 of 22 1 NM_004840.3 ENSP00000250617.6 Q15052-1
ARHGEF6ENST00000370622.5 linkc.223G>A p.Val75Ile missense_variant Exon 5 of 21 1 ENSP00000359656.1 Q15052-2
ARHGEF6ENST00000370620.5 linkc.223G>A p.Val75Ile missense_variant Exon 5 of 21 2 ENSP00000359654.1 Q15052-2

Frequencies

GnomAD3 genomes
AF:
0.00147
AC:
164
AN:
111617
Hom.:
2
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00359
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000476
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00446
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000565
Gnomad OTH
AF:
0.00199
GnomAD2 exomes
AF:
0.000784
AC:
140
AN:
178667
AF XY:
0.000471
show subpopulations
Gnomad AFR exome
AF:
0.00420
Gnomad AMR exome
AF:
0.0000735
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00211
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000647
Gnomad OTH exome
AF:
0.000680
GnomAD4 exome
AF:
0.000995
AC:
1088
AN:
1093790
Hom.:
0
Cov.:
28
AF XY:
0.000890
AC XY:
320
AN XY:
359524
show subpopulations
African (AFR)
AF:
0.00558
AC:
147
AN:
26344
American (AMR)
AF:
0.000142
AC:
5
AN:
35115
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19307
East Asian (EAS)
AF:
0.00537
AC:
162
AN:
30162
South Asian (SAS)
AF:
0.0000744
AC:
4
AN:
53795
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40409
Middle Eastern (MID)
AF:
0.000738
AC:
3
AN:
4065
European-Non Finnish (NFE)
AF:
0.000839
AC:
704
AN:
838695
Other (OTH)
AF:
0.00137
AC:
63
AN:
45898
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
40
81
121
162
202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00147
AC:
164
AN:
111669
Hom.:
2
Cov.:
23
AF XY:
0.00133
AC XY:
45
AN XY:
33879
show subpopulations
African (AFR)
AF:
0.00358
AC:
110
AN:
30731
American (AMR)
AF:
0.000475
AC:
5
AN:
10525
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2648
East Asian (EAS)
AF:
0.00447
AC:
16
AN:
3579
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2692
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5978
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.000565
AC:
30
AN:
53089
Other (OTH)
AF:
0.00197
AC:
3
AN:
1523
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000958
Hom.:
32
Bravo
AF:
0.00169
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000346
AC:
1
ESP6500AA
AF:
0.00339
AC:
13
ESP6500EA
AF:
0.000743
AC:
5
ExAC
AF:
0.000907
AC:
110

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Mar 30, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Uncertain:1Benign:1
Apr 20, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 01, 2014
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.V229I variant (also known as c.685G>A), located in coding exon 6 of the ARHGEF6 gene, results from a G to A substitution at nucleotide position 685. The valine at codon 229 is replaced by isoleucine, an amino acid with highly similar properties. This variant was previously reported in the SNPDatabase as rs75329154. Based on data from the 1000 Genomes Project, the A allele has an overall frequency of approximately 0% (0/503) total male alleles studied.. Based on data from the NHLBI Exome Sequencing Project (ESP), the A allele has an overall frequency of approximately 0.08% (2/2443) total male alleles studied, having been observed in 0.18% (1/571) African American male alleles and 0.05% (1/1872) European American male alleles. This amino acid position is not conserved on species alignment. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. -

ARHGEF6-related disorder Benign:1
Oct 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Non-syndromic X-linked intellectual disability Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.89
T
BayesDel_noAF
Benign
-1.1
CADD
Benign
11
DANN
Benign
0.34
DEOGEN2
Benign
0.15
.;.;T
FATHMM_MKL
Benign
0.48
N
LIST_S2
Benign
0.66
.;T;T
M_CAP
Benign
0.0037
T
MetaRNN
Benign
0.0074
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.26
.;.;N
PhyloP100
0.14
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.41
N;N;N
REVEL
Benign
0.030
Sift
Benign
0.44
T;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
.;.;B
Vest4
0.071
MVP
0.19
MPC
0.23
ClinPred
0.0016
T
GERP RS
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.036
gMVP
0.11
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75329154; hg19: chrX-135814308; API